Morning Star | Five Qiming Venture Partners Portfolio Companies Named to BEYOND Awards MedTech Transcendence and Health Leadership Lists
The BEYOND Awards Medical Technology Transcendence List seeks to identify and honor the transcendent forces in medical technology that demonstrate exceptional innovation capabilities and achieve "defining industry top standards"; the Great Health Navigation List focuses on leading enterprises that truly meet consumer health needs and exhibit strong growth potential and outstanding innovation capabilities.
At the recently held BEYOND International Technology Innovation Expo (BEYOND Expo), the BEYOND Awards Healthcare Technology Transcendence List and Great Health Navigation List were officially announced. The former aims to identify and recognize transformative forces in healthcare technology that demonstrate exceptional innovation capabilities and achieve "defining top-tier industry standards"; the latter focuses on pioneering enterprises that truly meet consumer health needs while demonstrating strong growth potential and outstanding innovation capabilities.
Qiming Venture Partners portfolio companies Dingke Medical, Wanzhong Yixin, Xinsu Technology, and Insilico Medicine were selected for the BEYOND Awards Healthcare Technology Transcendence List; Fukangshou was selected for the BEYOND Awards Great Health Navigation List.
Dingke Medical, Wanzhong Yixin, Xinsu Technology, Insilico Medicine
Selected for
BEYOND Awards Healthcare Technology Transcendence List
Fukangshou
Selected for
BEYOND Awards Great Health Navigation List
· BEYOND Awards Healthcare Technology Transcendence List
With a global perspective on innovation, the organizers constructed a navigation index through a multi-dimensional, multi-layered evaluation model encompassing R&D strength and innovation ecosystem, market leadership and growth, social responsibility and sustainable development, internationalization strategy and results, and future vision and strategic planning to select listed companies.
· BEYOND Awards Great Health Navigation List
With consumer needs at the core, the organizers constructed a navigation index through a multi-dimensional, multi-layered evaluation model encompassing product and service quality, product market influence, product innovation capabilities, and product-consumer need alignment to select listed companies.
Source | BEYOND Expo
Past Coverage
Qiming Stars | 3 Qiming Venture Partners Portfolio Elites Selected for 2024 MIT Technology Review 35 Innovators Under 35 China List Qiming Stars | Qiming Venture Partners and Over 10 Portfolio Companies Selected for 2024 China Healthcare Industry Investment and Financing Glory List Qiming Honors | Qiming Venture Partners and 50+ Portfolio Companies Named to 2025 Future Healthcare 100 List
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total committed capital reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Over 80 companies have become recognized unicorns or super-unicorns.
Many Qiming Venture Partners portfolio companies have grown into the most influential companies in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, ClinChoice, Belief BioMed, Biren Technology, among others.